From Financial Modeling Prep: 2025-02-11 07:00:06

Hologic, Inc. (NASDAQ:HOLX) is a top medical technology company specializing in women’s health, offering a wide range of products and services. Its financial performance shows a Return on Invested Capital (ROIC) of 10.04%, exceeding its Weighted Average Cost of Capital (WACC) of 8.24%.

Henry Schein, Inc. reports a ROIC of 4.90% against a WACC of 7.37%, resulting in a ROIC to WACC ratio of 0.66, potentially making it less appealing to investors. DENTSPLY SIRONA Inc. faces a tougher situation with a negative ROIC of -5.73% and a WACC of 7.12%, leading to a ROIC to WACC ratio of -0.80.

ResMed Inc. stands out with a ROIC of 20.06% and a WACC of 7.50%, achieving a ROIC to WACC ratio of 2.68, indicating strong operational efficiency and growth potential. Meanwhile, Laboratory Corporation of America Holdings and The Cooper Companies, Inc. have ROIC to WACC ratios of 0.67 and 0.50, respectively, potentially making them less attractive to investors.



Read more at Financial Modeling Prep:: Hologic, Inc. (NASDAQ:HOLX) Surpasses Cost of Capi…